Cargando…

Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours

BACKGROUND: The prognostic significance of lymph nodes (LNs) metastases and the optimum number of LN yield in gastroenteropancreatic neuroendocrine tumours (GEP NETs) undergoing curative resection is still debatable. Many studies have demonstrated that cure rate for patients with GEP NETs can be imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiramel, Jaseela, Almond, Rose, Slagter, Astrid, Khan, Adeel, Wang, Xin, Lim, Kok Haw Jonathan, Frizziero, Melissa, Chakrabarty, Bipasha, Minicozzi, Annamaria, Lamarca, Angela, Mansoor, Wasat, Hubner, Richard A, Valle, Juan William, McNamara, Mairéad Geraldine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186236/ https://www.ncbi.nlm.nih.gov/pubmed/32355642 http://dx.doi.org/10.5306/wjco.v11.i4.205

Ejemplares similares

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres
por: Frizziero, Melissa, et al.
Publicado: (2019)

Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
por: Frizziero, Melissa, et al.
Publicado: (2020)

Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice
por: Lamarca, Angela, et al.
Publicado: (2022)

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Chiramel, Jaseela, et al.
Publicado: (2017)

Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice
por: Lamarca, Angela, et al.
Publicado: (2019)

PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours
por: Lamarca, Angela, et al.
Publicado: (2018)

The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases
por: Kapacee, Zainul-Abedin, et al.
Publicado: (2022)

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?
por: Frizziero, Melissa, et al.
Publicado: (2021)

Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours
por: Lewis, Alexandra R, et al.
Publicado: (2018)

Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice
por: Fulton, Alexander JP, et al.
Publicado: (2019)

Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis
por: McNamara, Mairéad G., et al.
Publicado: (2020)

Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer
por: Pihlak, Rille, et al.
Publicado: (2023)

Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter
por: Exarchou, Klaire, et al.
Publicado: (2022)

C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group
por: Komaç, Ömer, et al.
Publicado: (2019)

Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients
por: Huang, Yu-Chen, et al.
Publicado: (2021)

The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
por: Abdul Rahman, Rozana, et al.
Publicado: (2021)

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
por: Foy, Victoria, et al.
Publicado: (2023)

Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review
por: Shotton, Rohan, et al.
Publicado: (2021)

NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC)
por: Craig, Zoe, et al.
Publicado: (2020)

The Potential Role of Liquid Biopsies in Advancing the Understanding of Neuroendocrine Neoplasms
por: Shah, Dinakshi, et al.
Publicado: (2021)

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
por: Galdy, Salvatore, et al.
Publicado: (2016)

Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022)

Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers
por: Metcalf, Robert L, et al.
Publicado: (2017)

Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations
por: Papaxoinis, George, et al.
Publicado: (2018)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes
por: Saavedra, Cristina, et al.
Publicado: (2019)

African Americans are less likely to receive curative treatment for hepatocellular carcinoma
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes
por: Taboada, Rodrigo G, et al.
Publicado: (2022)

Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer
por: Melli, Filippo, et al.
Publicado: (2021)

Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Risk factors for blood transfusion and its prognostic implications in curative gastrectomy for gastric cancer
por: Kawakami, Lucas Eiki, et al.
Publicado: (2023)

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
por: Najran, Pavan, et al.
Publicado: (2017)

Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers
por: Lamarca, Angela, et al.
Publicado: (2020)

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
por: Megdanova-Chipeva, Vera G., et al.
Publicado: (2020)

Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection
por: Deng, Li-Ming, et al.
Publicado: (2021)

Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection
por: Sakamoto, Yuzuru, et al.
Publicado: (2022)

Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy
por: Szor, Daniel Jose, et al.
Publicado: (2023)

Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery
por: Ramos, Marcus Fernando Kodama Pertille, et al.
Publicado: (2021)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
por: McNamara, Mairéad G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hkv7ebk9vilseg79vtrg78fjil